These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 28538024)

  • 1. Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trials.
    Thase ME; Edwards J; Durgam S; Chen C; Chang CT; Mathews M; Gommoll CP
    Int Clin Psychopharmacol; 2017 Sep; 32(5):281-288. PubMed ID: 28538024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder.
    Durgam S; Chen C; Migliore R; Prakash C; Edwards J; Findling RL
    Paediatr Drugs; 2018 Aug; 20(4):353-363. PubMed ID: 29633166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measures of suicidality in phase 3 clinical trials of levomilnacipran ER in adults with major depressive disorder.
    Thase ME; Gommoll C; Chen C; Kramer K; Khan A; Durgam S
    CNS Spectr; 2017 Dec; 22(6):475-483. PubMed ID: 28521846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-term and open-label, long-term extension trials.
    Mahableshwarkar AR; Affinito J; Reines EH; Xu J; Nomikos G; Jacobsen PL
    CNS Spectr; 2020 Jun; 25(3):352-362. PubMed ID: 31199210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder.
    Gommoll C; Durgam S; Mathews M; Forero G; Nunez R; Tang X; Thase ME
    Depress Anxiety; 2015 Jun; 32(6):451-9. PubMed ID: 25891440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial.
    Clayton AH; Gommoll C; Chen D; Nunez R; Mathews M
    Int Clin Psychopharmacol; 2015 Jul; 30(4):216-23. PubMed ID: 26039688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
    JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study.
    Gommoll C; Forero G; Mathews M; Nunez R; Tang X; Durgam S; Sambunaris A
    Int Clin Psychopharmacol; 2015 Nov; 30(6):297-306. PubMed ID: 26291335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy.
    Kraus JE; Horrigan JP; Carpenter DJ; Fong R; Barrett PS; Davies JT
    J Affect Disord; 2010 Jan; 120(1-3):40-7. PubMed ID: 19439363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of vilazodone for the treatment of depressive and anxiety disorders.
    Stuivenga M; Giltay EJ; Cools O; Roosens L; Neels H; Sabbe B
    Expert Opin Pharmacother; 2019 Feb; 20(3):251-260. PubMed ID: 30475091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial.
    Durgam S; Gommoll C; Forero G; Nunez R; Tang X; Mathews M; Sheehan DV
    J Clin Psychiatry; 2016 Dec; 77(12):1687-1694. PubMed ID: 27232052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post Hoc Analyses of Anxiety Measures in Adult Patients With Generalized Anxiety Disorder Treated With Vilazodone.
    Khan A; Durgam S; Tang X; Ruth A; Mathews M; Gommoll CP
    Prim Care Companion CNS Disord; 2016; 18(2):. PubMed ID: 27486544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial.
    Durgam S; Gommoll C; Migliore R; Chen C; Chang CT; Aguirre M; Thase ME
    Int Clin Psychopharmacol; 2018 Nov; 33(6):304-311. PubMed ID: 30044247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder.
    Khan A; Cutler AJ; Kajdasz DK; Gallipoli S; Athanasiou M; Robinson DS; Whalen H; Reed CR
    J Clin Psychiatry; 2011 Apr; 72(4):441-7. PubMed ID: 21527122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vilazodone efficacy in subgroups of patients with major depressive disorder: a post-hoc analysis of four randomized, double-blind, placebo-controlled trials.
    Kornstein S; Chang CT; Gommoll CP; Edwards J
    Int Clin Psychopharmacol; 2018 Jul; 33(4):217-223. PubMed ID: 29608461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vilazodone: a review in major depressive disorder in adults.
    McCormack PL
    Drugs; 2015 Nov; 75(16):1915-23. PubMed ID: 26496736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: Analysis of the CLARITY study.
    Shelton RC; Fava M; Freeman MP; Thase ME; Papakostas GI; Jha MK; Trivedi MH; Dirks B; Liu K; Stankovic S
    J Affect Disord; 2020 Dec; 277():478-485. PubMed ID: 32871535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of vilazodone on sexual function during the treatment of major depressive disorder.
    Clayton AH; Kennedy SH; Edwards JB; Gallipoli S; Reed CR
    J Sex Med; 2013 Oct; 10(10):2465-76. PubMed ID: 23216998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up.
    Findling RL; McCusker E; Strawn JR
    J Child Adolesc Psychopharmacol; 2020 Jul; 30(6):355-365. PubMed ID: 32460523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.